ZIVO

Zivo Bioscience (ZIVO)

Zivo Bioscience Inc

から:

Regulatory News

Text Search:

次の項目別のソート:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:ZIVO

1 2 3 4 次へ >>

日付	受信時刻	ニュースソース	見出し	コード	企業名
2024/04/27	02 : 36	Edgar (US Regulatory)	Form ARS - Annual Report to Security Holders	NASDAQ:ZIVO	Zivo Bioscience Inc
2024/04/26	21 : 05	Edgar (US Regulatory)	Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material	NASDAQ:ZIVO	Zivo Bioscience Inc
2024/04/26	21 : 00	Edgar (US Regulatory)	Form DEF 14A - Other definitive proxy statements	NASDAQ:ZIVO	Zivo Bioscience Inc
2024/04/10	00 : 49	Edgar (US Regulatory)	Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]	NASDAQ:ZIVO	Zivo Bioscience Inc
2024/03/14	22 : 16	Edgar (US Regulatory)	Form SCHEDULE 13D/A - General statement of acquisition of beneficial ownership: [Amend]	NASDAQ:ZIVO	Zivo Bioscience Inc
2024/02/16	06 : 45	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:ZIVO	Zivo Bioscience Inc
2024/02/15	22 : 54	Edgar (US Regulatory)	Form 25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities	NASDAQ:ZIVO	Zivo Bioscience Inc
2024/02/08	06 : 54	Business Wire	ZIVO Bioscience Reports Additional Findings from Positive 42-Day Coccidiosis Challenge Study	NASDAQ:ZIVO	Zivo Bioscience Inc
2024/01/29	22 : 00	Business Wire	ZIVO Bioscience Announces Uplisting to OTCQB Market	NASDAQ:ZIVO	Zivo Bioscience Inc
2024/01/23	07 : 15	Edgar (US Regulatory)	Form SC 13D - General statement of acquisition of beneficial ownership	NASDAQ:ZIVO	Zivo Bioscience Inc
2024/01/18	06 : 11	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:ZIVO	Zivo Bioscience Inc
2024/01/06	07 : 17	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:ZIVO	Zivo Bioscience Inc
2024/01/05	06 : 05	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:ZIVO	Zivo Bioscience Inc
2024/01/04	07 : 23	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:ZIVO	Zivo Bioscience Inc
2024/01/03	06 : 12	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:ZIVO	Zivo Bioscience Inc
2023/11/27	23 : 29	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:ZIVO	Zivo Bioscience Inc
2023/11/23	06 : 21	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:ZIVO	Zivo Bioscience Inc
2023/11/14	06 : 18	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:ZIVO	Zivo Bioscience Inc
2023/11/03	23 : 18	Edgar (US Regulatory)	Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]	NASDAQ:ZIVO	Zivo Bioscience Inc
2023/10/31	02 : 20	Edgar (US Regulatory)	Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]	NASDAQ:ZIVO	Zivo Bioscience Inc
2023/10/30	21 : 30	Business Wire	ZIVO Bioscience Initiates 42-Day Validation Study with Immune-Modulating Product for the Prevention and Treatment of Coccidiosis in Broiler Chickens	NASDAQ:ZIVO	Zivo Bioscience Inc
2023/10/26	21 : 56	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:ZIVO	Zivo Bioscience Inc
2023/10/26	21 : 30	Business Wire	ZIVO Bioscience Announces Reverse Stock Split	NASDAQ:ZIVO	Zivo Bioscience Inc
2023/10/05	06 : 08	Edgar (US Regulatory)	Form S-1 - General form for registration of securities under the Securities Act of 1933	NASDAQ:ZIVO	Zivo Bioscience Inc
2023/10/03	21 : 30	GlobeNewswire Inc.	ZIVO Bioscience to Present at the Dawson James Small Cap Growth Conference	NASDAQ:ZIVO	Zivo Bioscience Inc
2023/09/21	22 : 35	GlobeNewswire Inc.	Dawson James Securities Announces October Date for 8th Annual Small Cap Growth Conference	NASDAQ:ZIVO	Zivo Bioscience Inc
2023/09/20	05 : 15	Business Wire	Trial Results Confirm Efficacy of ZIVO Bioscience’s Non-Antibiotic Product Candidate for the Prevention and Treatment of Coccidiosis in Broiler Chickens	NASDAQ:ZIVO	Zivo Bioscience Inc
2023/08/17	04 : 00	Business Wire	ZIVO Announces Commitment by ZWorldwide to Purchase all Zivolife™ Algal Biomass Product Produced Over the Next 18 Months	NASDAQ:ZIVO	Zivo Bioscience Inc
2023/08/15	05 : 17	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:ZIVO	Zivo Bioscience Inc
2023/08/10	05 : 17	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:ZIVO	Zivo Bioscience Inc